Japanese drug companies modifies their strategy in market entry.

After the IMF economic crisis many foreign multinational pharmaceutical corporations were emerged out of the depressed business environment with more aggressive market entry by means of taking over the shares owned by their Korean business counter partners for their whole management controls.

Japanese pharmaceutical companies used to play their business operation in Korea with their Korean b...